HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Dr. Lal Pathlabs’ arm gets nod to acquire further 10% stake in APRL PathLabs
Jan-31-2023

Dr. Lal Pathlabs’ Wholly Owned Subsidiary--- PathLabs Unifiers (PUPL) has received approval for the acquisition of further 10% equity stake in its Subsidiary Company i.e. APRL PathLabs (APRL). Object of acquisition is to strengthen the company’s presence in the state of Gujarat, India. Cost of acquisition is around Rs 7.50 Million. Post this acquisition, total equity stake of PUPL in APRL will increase from 70% to 80%. The Board of Directors of the company in their meeting held on January 30, 2023 approved the same.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

  RELATED NEWS >>